Samineh Sehatbakhsh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Samineh Sehatbakhsh has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Robert Chait
From the University of Miami Miller School of Medicine, Graduate Medical Education, Department of Medicine, Devision of Cardiology at JFK Medical Center, Atlantis, FL
3 shared publicationsElie Donath
From the University of Miami Miller School of Medicine, Graduate Medical Education, Department of Medicine, Devision of Cardiology at JFK Medical Center, Atlantis, FL
2 shared publicationsWaqas Ghumman
From the University of Miami Miller School of Medicine, Graduate Medical Education, Department of Medicine, Devision of Cardiology at JFK Medical Center, Atlantis, FL
2 shared publicationsAlexander Kushnir
From the University of Miami Miller School of Medicine, Graduate Medical Education, Department of Medicine, Devision of Cardiology at JFK Medical Center, Atlantis, FL
1 shared publication- Alexander Kushnir
Leon H. Charney Division of Cardiology, Cardiac Electrophysiology, NYU Langone Health, New York University Grossman School of Medicine, New York, USA
1 shared publication Andrea Mignatti
Division of Cardiology Montefiore Medical Center New York 10467 NY USA
1 shared publication
Latest Publications
- 1 September 2023
- Published by Taylor & Francis in Future Cardiology
- Vol. 19 (12) , 615-623
A Novel Therapy in Microvascular Obstruction in ST-elevation Myocardial Infarction: pressure-controlled Intermittent Coronary Sinus Occlusion Therapy
Percutaneous coronary intervention (PCI) has transformed the management of ST-elevation myocardial infarction (STEMI) due to a reduction in early mortality and need for repeat revascularization. Ho...
- 1 September 2023
- Published by Taylor & Francis in Future Cardiology
- Vol. 19 (12) , 615-623
A Novel Therapy in Microvascular Obstruction in ST-elevation Myocardial Infarction: pressure-controlled Intermittent Coronary Sinus Occlusion Therapy
Percutaneous coronary intervention (PCI) has transformed the management of ST-elevation myocardial infarction (STEMI) due to a reduction in early mortality and need for repeat revascularization. Ho...
- 1 September 2018
- Published by Wolters Kluwer Health in Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine
- Vol. 17 (3) , 147-150
Importance of a Risk Stratification Strategy to Identify High-risk Patients Presenting With Cocaine-associated Acute Coronary Syndrome
Objective: Current guidelines recommend treating patients with cocaine-associated chest pain, unstable angina, or myocardial infarction similarly to patients with traditional acute coronary syndrome (ACS). Risk stratifying these patients could potentially reduce unnecessary procedures and improve resource utilization. Methods: This is a retrospective cross-sectional analysis of 258 patients presenting with cocaine-associated ACS who underwent cardiac catheterization in a community teaching hospital between 2006 and 2015. The primary outcome was the prevalence of acute obstructive coronary artery disease (CAD) requiring percutaneous coronary intervention and coronary artery bypass grafting compared with that of patients with normal coronary or nonobstructive disease. Results: Of the studied population, 36% had obstructive CAD requiring intervention and 64% were found to have normal coronaries or nonobstructive disease. Significant risk factors for obstructive CAD were older age, history of CAD, diabetes mellitus, dyslipidemia, ST-segment–elevation myocardial infarction, and troponin elevation. A logistic model was developed based on these variables, applied to the studied population, and was found to have 93% sensitivity in predicting the likelihood of obstructive CAD. Conclusions: Cardiac catheterization in patients presenting with cocaine-associated ACS may be overutilized. A predictive model based on clinical risk factors may help individualize patient care and reduce unnecessary invasive diagnostic interventions.
- 1 September 2018
- Published by Wolters Kluwer Health in Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine
- Vol. 17 (3) , 147-150
Importance of a Risk Stratification Strategy to Identify High-risk Patients Presenting With Cocaine-associated Acute Coronary Syndrome
Objective: Current guidelines recommend treating patients with cocaine-associated chest pain, unstable angina, or myocardial infarction similarly to patients with traditional acute coronary syndrome (ACS). Risk stratifying these patients could potentially reduce unnecessary procedures and improve resource utilization. Methods: This is a retrospective cross-sectional analysis of 258 patients presenting with cocaine-associated ACS who underwent cardiac catheterization in a community teaching hospital between 2006 and 2015. The primary outcome was the prevalence of acute obstructive coronary artery disease (CAD) requiring percutaneous coronary intervention and coronary artery bypass grafting compared with that of patients with normal coronary or nonobstructive disease. Results: Of the studied population, 36% had obstructive CAD requiring intervention and 64% were found to have normal coronaries or nonobstructive disease. Significant risk factors for obstructive CAD were older age, history of CAD, diabetes mellitus, dyslipidemia, ST-segment–elevation myocardial infarction, and troponin elevation. A logistic model was developed based on these variables, applied to the studied population, and was found to have 93% sensitivity in predicting the likelihood of obstructive CAD. Conclusions: Cardiac catheterization in patients presenting with cocaine-associated ACS may be overutilized. A predictive model based on clinical risk factors may help individualize patient care and reduce unnecessary invasive diagnostic interventions.
- 29 November 2017
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 41 (2) , 218-220
A case of electromagnetic interference between HeartMate 3 LVAD and implantable cardioverter defibrillator
Implantable cardioverter defibrillators (ICDs) have been shown to have a significant benefit in reducing sudden cardiac death (SCD) in patients with systolic heart failure. Additionally, cardiac devices as a bridge to transplant or destination therapy are often used in patients with end‐stage systolic heart failure. As a result, most patients with left ventricular assist devices (LVADs) also have an ICD. Here, we present an electromagnetic interference (EMI) between HeartMate 3 LVAD and ICD. This issue might be critical for both electrophysiologists and advanced heart failure cardiologists to understand prior to implantation of ICD/LVADs in these patients.
- 29 November 2017
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 41 (2) , 218-220
A case of electromagnetic interference between HeartMate 3 LVAD and implantable cardioverter defibrillator
Implantable cardioverter defibrillators (ICDs) have been shown to have a significant benefit in reducing sudden cardiac death (SCD) in patients with systolic heart failure. Additionally, cardiac devices as a bridge to transplant or destination therapy are often used in patients with end‐stage systolic heart failure. As a result, most patients with left ventricular assist devices (LVADs) also have an ICD. Here, we present an electromagnetic interference (EMI) between HeartMate 3 LVAD and ICD. This issue might be critical for both electrophysiologists and advanced heart failure cardiologists to understand prior to implantation of ICD/LVADs in these patients.